Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of Thursday, August 20, 2026.
OPERATING CASH FLOW YIELD
N/A
Shoulder Innovations, Inc.
Market Cap
$482.37M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$495.36M
Operating Cash Flow Yield
6.10%
TTM Avg
6.72%
3Y Avg
6.88%
5Y Avg
5.78%
Market Cap
$1.21B
Operating Cash Flow Yield
21.79%
TTM Avg
24.29%
3Y Avg
19.77%
5Y Avg
14.66%
Market Cap
$2.21B
Operating Cash Flow Yield
14.43%
TTM Avg
10.60%
3Y Avg
9.99%
5Y Avg
8.90%
Market Cap
$3.25B
Operating Cash Flow Yield
3.82%
TTM Avg
4.62%
3Y Avg
2.90%
5Y Avg
2.90%
Market Cap
$6.94B
Operating Cash Flow Yield
3.70%
TTM Avg
4.09%
3Y Avg
3.07%
5Y Avg
2.83%
Market Cap
$8.37B
Operating Cash Flow Yield
40.65%
TTM Avg
26.44%
3Y Avg
22.76%
5Y Avg
21.40%
Market Cap
$9.80B
Operating Cash Flow Yield
5.04%
TTM Avg
6.43%
3Y Avg
5.32%
5Y Avg
4.39%
Market Cap
$10.17B
Operating Cash Flow Yield
6.85%
TTM Avg
6.49%
3Y Avg
7.09%
5Y Avg
6.81%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $482.37M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $495.36M | 6.10% | 6.72% | 6.88% | 5.78% |
| Teladoc Health, Inc. (TDOC)vs › | $1.21B | 21.79% | 24.29% | 19.77% | 14.66% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | 14.43% | 10.60% | 9.99% | 8.90% |
| TransMedics Group, Inc. (TMDX)vs › | $3.25B | 3.82% | 4.62% | 2.90% | 2.90% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.94B | 3.70% | 4.09% | 3.07% | 2.83% |
| Oscar Health, Inc. (OSCR)vs › | $8.37B | 40.65% | 26.44% | 22.76% | 21.40% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.80B | 5.04% | 6.43% | 5.32% | 4.39% |
| Henry Schein, Inc. (HSIC)vs › | $10.17B | 6.85% | 6.49% | 7.09% | 6.81% |
| Universal Health Services, Inc. (UHS)vs › | $10.43B | 17.42% | 16.02% | 14.11% | 12.65% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
